Physician profile
Robert M Thornsberry
NPI 1922118165
$6,316.34
in general payments reported to CMS, 2019-2025
12 companies · $275 in 2025
The $275 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,512 · 2020: $256 · 2021: $1,313 · 2022: $324 · 2023: $1,425 · 2024: $212 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,033 · Travel and Lodging: $879.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,032.82 |
| Travel and Lodging | $879.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,945.72 | 2019-2025 | Triathlon, Mako |
| Arthrex, INC. | $1,423.08 | 2022-2023 | |
| United Orthopedics LLC | $1,373.99 | 2021-2023 | |
| Depuy Synthes Sales INC. | $190.61 | 2019-2024 | Na |
| Miach Orthopaedics, INC. | $183.93 | 2025 | |
| Acumed LLC | $110.68 | 2019 | |
| Baxter Healthcare | $21.48 | 2021 | |
| Heron Therapeutics, INC. | $20.40 | 2021 | |
| Bioventus LLC | $17.73 | 2019 | |
| Davol INC. | $14.38 | 2023 | Arista Ah Flexitip |
| Pacira Therapeutics, INC. | $14.34 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$12,818.88 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Thornsberry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.